ライフサイエンスコーパス: incontinence

1 pulmonary disease (COPD), asthma, or urinary incontinence.

2 ng 381 women with refractory urgency urinary incontinence.

3 hy, dysarthria, as well as urinary and bowel incontinence.

4 lling refractory episodes of urgency urinary incontinence.

5 d to new treatments for diseases like faecal incontinence.

6 this tone leads to disorders such as faecal incontinence.

7 ad the skills to manage patients with faecal incontinence.

8 PTNS) is a new ambulatory therapy for faecal incontinence.

9 ary frequency, urgency, and at times urinary incontinence.

10 ation in the treatment of adults with faecal incontinence.

11 electrical stimulation in adults with faecal incontinence.

12 incter muscle as a method for treating fecal incontinence.

13 phenotypes in defecatory disorders and fecal incontinence.

14 ever, this is associated with a high rate of incontinence.

15 sing men with the symptoms of urgency and/or incontinence.

16 Some patients reported symptoms of fecal incontinence.

17 ce regarding the efficacy of PTNS in urinary incontinence.

18 dification can lessen urgency, nocturia, and incontinence.

19 ogic surgery, urinary retention, and urinary incontinence.

20 fashion which minimizes the risk of urinary incontinence.

21 No patient developed fecal incontinence.

22 s for treating patients with refractory urge incontinence.

23 ositive effect in men with postprostatectomy incontinence.

24 management of defecatory disorders and fecal incontinence.

25 treatment of the components of mixed urinary incontinence.

26 ssessment of men with urinary urgency and/or incontinence.

27 about the long-term outcome of SNS for fecal incontinence.

28 l-sling surgery in women with stress urinary incontinence.

29 eurons, astroglial cells and myelin; urinary incontinence.

30 r group developed ischemic colitis and fecal incontinence.

31 dication or indwelling catheters for urinary incontinence.

32 re < 3), and 6 patients (8.5%) had recurrent incontinence.

33 ing nerve damage to create models of urinary incontinence.

34 olapse are at risk for postoperative urinary incontinence.

35 equency of daily episodes of urgency urinary incontinence.

36 onths, allowing for subsequent treatment for incontinence.

37 ical option in the treatment of severe fecal incontinence.

38 djusted probability of postoperative urinary incontinence.

39 peutic options for women affected by urinary incontinence.

40 Acquired deformities (13%), incontinence (11%), non-injury wounds (9%), and pelvic o

41 1 more cases [95% CI, 3 to 22]), and urinary incontinence (1261 more cases [95% CI, 880 to 1689]).

42 al atrophy (P = .01), nonobstructive urinary incontinence (18.5% vs 3.9%; P = .04), and syncope (37%

43 el movements/week and </= 1 episode of fecal incontinence/2 weeks, from study weeks 5-8 (responders).

44 The most commonly investigated was faecal incontinence (32 studies, 91%).

45 %] to 15% [12%-20%], p < 0.001), and urinary incontinence (43% [39%-47%) to 29% [24%-35%], p < 0.001)

46 ration (4.1% vs. 3.0%, p = 0.758) or urinary incontinence (5.0% vs. 0%, p = 0.195).

47 12 points for sexual function, 6 for urinary incontinence, 5 for urinary irritative symptoms, 5 for b

48 o 12 for sexual function, 6 to 9 for urinary incontinence, 5 to 7 for urinary irritative symptoms, an

49 in the placebo group had a history of fecal incontinence; 60.4% and 55.1% in the prucalopride and pl

50 22 more per 10 000 woman-years), and urinary incontinence (872 more per 10 000 woman-years).

51 ke (9 more cases [95% CI, 2 to 19]), urinary incontinence (876 more cases [95% CI, 606 to 1168]), and

52 Mixed urinary incontinence, a condition of both stress and urge urinar

53 ender, unable to self-ambulate, all types of incontinence, additional linen layers, longer lengths of

54 activity are the major categories of urinary incontinence affecting men.

55 Male urinary incontinence affects a significant number of elderly men

56 Stress urinary incontinence after prostate cancer treatment is common.

57 Urinary incontinence after treatment for prostate cancer is comm

58 CI 0.49-1.79]); an increased risk of further incontinence (aIRR 3.20 [2.06-4.96]) and prolapse surger

59 sults support the use of mesh procedures for incontinence, although further research on longer term o

60 sults support the use of mesh procedures for incontinence, although further research on longer term o

61 ted with better resident outcomes of urinary incontinence among organizational factors.

62 gnosis in primary care of urinary and faecal incontinence among people aged 60-89 with dementia, and

63 e preoperative incidence (11.1% vs 37.5% for incontinence and 15.6% vs 54.0% for constipation).

64 0-17); 28% of patients had never experienced incontinence and 60% had fragmentation.

65 Stress urinary incontinence, overflow incontinence and detrusor overactivity are the major cat

66 Urinary incontinence and erectile and sexual dysfunction were ea

67 ulation to treat overactive bladder, urinary incontinence and interstitial cystitis (also known as bl

68 ads to severe bladder dysfunction, including incontinence and lower urinary tract symptoms; with the

69 Both rates of fecal incontinence and obstructed defecation decreased signifi

70 conservative management in men with urinary incontinence and other LUTS.

71 ntegrin signaling from urothelium results in incontinence and overactive bladder due to abnormal mech

72 out the safety of surgery for stress urinary incontinence and pelvic organ prolapse using transvagina

73 hs after surgery, he had mild stress urinary incontinence and PSA of < 0.1 ng/mL.

74 Heavy incontinence and radiation history are strongly associat

75 rned about the potential for greater urinary incontinence and/or urinary irritation associated with t

76 outcome domains (including fecal urgency and incontinence), and three oncological outcome domains (in

77 tion and irritation, 9.7 to 10.5 for urinary incontinence, and 5.7 to 6.1 for bowel problems.

78 ies, megacolon/megarectum, degree of soiling/incontinence, and anorectal manometry profile(s).

79 urinary obstruction and irritation, urinary incontinence, and bowel problems-each scored from 0 (no

80 swallowing difficulties, tinnitus, and fecal incontinence, and he had undergone cataract surgery at t

81 three times the rate of diagnosis of urinary incontinence, and more than four times the rate of faeca

82 balance difficulties with falls and urinary incontinence, and one was wheelchair bound.

83 tion of fistula recurrence, residual urinary incontinence, and pregnancy after successful fistula clo

84 ted with lower rates of hemorrhage, maternal incontinence, and rare but serious neonatal outcomes.

85 sociodemographics, cognitive status, urinary incontinence, and self-reported ability to do activities

86 disease process in overactive bladder, urge incontinence, and spinal cord injury.

87 ch, frequency of defecation and incidence of incontinence, and the patients' perception of QOL.

88 en were eligible if they had current urinary incontinence, and were excluded if they had a third degr

89 to claims indicative of urethritis, urinary incontinence, and/or obstruction.

90 normal sphincter function without history of incontinence, any pretreatment staging or adenoma, expec

91 Group exercise-based programmes for urinary incontinence appear to be promising low-cost interventio

92 ive modes of electrical stimulation for urge incontinence are also briefly reviewed.

93 efficacy of primary interventions for faecal incontinence are few in number.

94 tance: Women with refractory urgency urinary incontinence are treated with sacral neuromodulation and

95 y tract symptoms (LUTS), such as urgency and incontinence, are common, especially among the elderly,

96 (NHIC), and 24 patients with stress urinary incontinence as controls were enrolled.

97 timulation in the treatment of men with urge incontinence, as well as evaluates the financial implica

98 r nerve damage, such as urinary retention or incontinence, as well as for the development of strategi

99 with a sling to prevent one case of urinary incontinence at 12 months was 6.3.

100 second primary end point was the presence of incontinence at 12 months, allowing for subsequent treat

101 surgery resulted in a lower rate of urinary incontinence at 3 and 12 months but higher rates of adve

102 statectomy was associated with worse urinary incontinence at 5 years (adjusted mean difference, -10.9

103 of sacral nerve stimulation (SNS) for fecal incontinence at 5 years after implantation and to identi

104 ean difference, 12.5 [95% CI, 6.2-18.7]) and incontinence at each time point through 5 years (adjuste

105 Among women with mixed urinary incontinence, behavioral and pelvic floor muscle therapy

106 in men compared with women, despite urinary incontinence being relatively common and burdensome in m

107 =65 years), gallbladder disease, and urinary incontinence; benefits included decreased hip fractures,

108 men with normal stool consistency and faecal incontinence bothersome enough to seek treatment, we wer

109 have complete resolution of urgency urinary incontinence but had higher rates of transient urinary r

110 ts only modest relief of male stress urinary incontinence, but may be recommended in some patients.

111 may benefit a subset of patients with fecal incontinence, but more controlled studies are needed.

112 ith weight loss, for treating stress urinary incontinence by performing anti-incontinence procedures

113 ntified, and studies have shown that urinary incontinence can have substantial negative impacts on va

114 rganizational factors that influence urinary incontinence care quality controlling for patient level

115 impact of organizational factors on urinary incontinence care quality defined as the improvement of

116 e (p=0.014), dysphagia (p=0.003) and urinary incontinence/catheterisation (p=0.000) were at higher ri

117 able as judged by the clinical team and with incontinence classified as stress, urge, mixed or 'funct

118 are common first-line treatments for faecal incontinence, clinicians could consider combining lopera

119 macological treatment of male stress urinary incontinence, confirming that duloxetine had a modest po

120 Surgical therapies for fecal incontinence continue to evolve and show promise in impr

121 Clinicians should prioritize urinary incontinence detection, identify and treat modifiable fa

122 nd anal cancers; inflammatory bowel disease; incontinence; diverticulitis; hemorrhoids; fistulas; and

123 nt data on the medical treatment of men with incontinence due to overactive bladder or to stress urin

124 Patient's age, improvement of urge incontinence during PNE, and sustained efficacy during t

125 months, and at least 1 stress and 1 urgency incontinence episode on a 3-day bladder diary.

126 tive predictors included improvement of urge incontinence episodes during percutaneous nerve evaluati

127 aseline mean number of daily urgency urinary incontinence episodes over 6 months, was measured with m

128 Deferment time and average number of weekly incontinence episodes were also estimated from a prospec

129 egular voiding intervals that reduce urgency incontinence episodes.

130 ded 24 cases of post-repair residual urinary incontinence, equivalent to a cumulative incidence of 23

131 cted defecation syndrome (ODS) in 40%, fecal incontinence (FI) in 22%, combination of ODS and FI in 2

132 spectively from patients implanted for fecal incontinence (FI) in 7 French centers between January 19

133 evels can contribute to development of fecal incontinence (FI) in women after menopause by altering n

134 Chronic diarrhea with fecal incontinence (FI) is a severe, underreported, and intrac

135 The prevalence of faecal incontinence (FI) varies worldwide, and in Malaysia is n

136 agement of common anorectal disorders: fecal incontinence (FI), functional anorectal pain and functio

137 ous tibial nerve stimulation (PTNS) in fecal incontinence (FI).

138 effective as stimulation at the ST for fecal incontinence (FI).

139 led fecal soiling and leads to passive fecal incontinence (FI).

140 ed 18 years or older with substantial faecal incontinence for whom conservative treatments (such as d

141 or pulmonary arterial hypertension, urinary incontinence, gastrointestinal and neuropsychiatric dise

142 man in his 30s with paraparesis and urinary incontinence had a long-segment thoracic lesion on spina

143 Surgical treatment of fecal incontinence has evolved from colostomy and direct repai

144 ontinence, including both stress and urgency incontinence, has adverse effects on a woman's quality o

145 of which limb motor deficit, dysphagia, and incontinence have declined between 2001 and 2018.

146 Fecal incontinence (hazard ratio [HR], 1.78; 95% confidence in

147 (HR: 1.95; 95% CI: 1.09-3.50; p = 0.02), and incontinence (HR: 2.29; 95% CI: 0.95-5.57; p = 0.07).

148 alls in 76%, pyramidal signs in 54%, urinary incontinence in 50% and dementia in 39%.Visual hallucina

149 vents of these procedures for stress urinary incontinence in England over 8 years.

150 adder, reduced maximal voiding pressures and incontinence in IgG control, but not sham or cis mAb tre

151 Void spot assays revealed age-dependent incontinence in IgG controls 8 months after injury, whil

152 Recent research has focused less on urinary incontinence in men compared with women, despite urinary

153 xcellent options for managing stress urinary incontinence in men, and recent data have allowed us to

154 d information on the epidemiology of urinary incontinence in men.

155 rvention has the potential to manage urinary incontinence in older women in communities largely outsi

156 TS) including urinary frequency, urgency and incontinence in patients with benign prostatic hyperplas

157 Incontinence in people with dementia is distressing, add

158 Successful and safe management of incontinence in people with dementia presents additional

159 The clinical management of urinary incontinence in people with dementia with medication and

160 pragmatically appropriate to manage urinary incontinence in select patients.

161 The rates of first diagnosis for faecal incontinence in the dementia cohort were 11.1 (10.4-11.9

162 t risk (95% confidence interval) for urinary incontinence in the dementia cohort, among men and women

163 and more than four times the rate of faecal incontinence, in UK primary care.

164 ed frequency, nocturia, with or without urge incontinence; in the absence of proven infection or othe

165 Specialist treatments for urgency incontinence include onabotulinumtoxinA and percutaneous

166 Mixed urinary incontinence, including both stress and urgency incontin

167 examined risk factors and impact of urinary incontinence, including lifestyle, comorbidities and med

168 Risks of tumor spillage and fecal incontinence induced by transanal extraction are not kno

169 For women with stress urinary incontinence, initial midurethral-sling surgery, as comp

170 Initial assessment of men with incontinence involves a focussed history, examination an

171 100 IU) in patients with non-neurogenic urge incontinence is 33 and 5%, respectively.

172 Fecal incontinence is a challenging condition with numerous av

173 Urinary incontinence is a common clinical problem, particularly

174 Fecal incontinence is a significant source of morbidity and de

175 Conservative treatment for urinary incontinence is an effective intervention and has been r

176 Urinary incontinence is an important condition affecting many re

177 Urinary incontinence is common in women, although few seek care

178 The treatment of male urinary incontinence is constantly evolving, with recent advance

179 ce for treatment of women with mixed urinary incontinence is lacking, as are clear diagnostic criteri

180 Incontinence is not an isolated symptom in men, but rath

181 Male urinary incontinence is often seen following prostate surgery an

182 a condition of both stress and urge urinary incontinence, is prevalent in 20% to 36% of women and is

183 Patients with stress urinary incontinence mainly suffer from malfunction of the ureth

184 Concerning urinary function, the grade of incontinence measured 1 year after the intervention was

185 Urgency incontinence medications, with timely reassessment of sy

186 d as first-line treatment for stress urinary incontinence; midurethral-sling surgery is generally rec

187 stent with the International Consultation on Incontinence modular Questionnaire modules.

188 inal surgery for prolapse and stress urinary incontinence, neither ULS nor SSLF was significantly sup

189 fer new avenues for the treatment of urinary incontinence of central origin.

190 should focus on understanding the effect of incontinence on quality of life, the patient's goals and

191 She denies fecal incontinence or change in stool caliber.

192 .None of the patients presented with urinary incontinence or erectile dysfunction.

193 uracy and improved comfort for patients with incontinence or voiding dysfunction.

194 At 3 months, the rate of urinary incontinence (or treatment) was 23.6% in the sling group

195 symptomatic orthostatic hypotension, urinary incontinence, or both) at diagnosis (n=62) had a worse p

196 Stress urinary incontinence, overflow incontinence and detrusor overact

197 participants received a standardised faecal incontinence patient education pamphlet and were followe

198 n 6-month mean number of episodes of urgency incontinence per day than did the 174 in the sacral neur

199 Women with at least one episode of faecal incontinence per month in the past 3 months were randoml

200 eduction in the number of episodes of faecal incontinence per week compared with 32 (31%) of 102 pati

201 % or greater reduction in episodes of faecal incontinence per week.

202 ons such as erectile dysfunction and urinary incontinence persist at high incidence rates.

203 andomized trials in women with mixed urinary incontinence populations are needed.

204 [8 constipation predominant (group 1) and 5 incontinence predominant (group 2)] had a 3-week trial o

205 h uncomplicated, demonstrable stress urinary incontinence, preoperative office evaluation alone was n

206 20 years or older undergoing a first, single incontinence procedure or prolapse procedure during 1997

207 2016, 16 660 women underwent a first, single incontinence procedure, 13 133 (79%) of which used mesh.

208 ress urinary incontinence by performing anti-incontinence procedures of both traditional and mid-uret

209 osure can lead to urinary frequency, urinary incontinence, proctitis, and erectile dysfunction.

210 e to overactive bladder or to stress urinary incontinence published in peer-reviewed journals.

211 inence Score (CCIS)], quality of life [Fecal-Incontinence Quality of Life Questionnaire (FIQL)], bowe

212 of life was assessed with the Rockwood Fecal Incontinence Quality of Life questionnaire.

213 luded complete resolution of urgency urinary incontinence, quality of life, use of catheters, and adv

214 atients were evaluated with the Wexner Fecal Incontinence Questionnaire after stoma closure.

215 n the modified International Consultation on Incontinence Questionnaire Male Lower Urinary Tract Symp

216 viours and the International Consultation on Incontinence Questionnaire-Female Lower Urinary Tract Sy

217 ethral bulking and oral medicines for stress incontinence remains low because of inconsistent results

218 he MSC secretome in models of stress urinary incontinence, renal disease, bladder dysfunction and ere

219 ADI) is a major contributor in the rectoanal incontinence (RI).

220 Symptom severity [Cleveland Clinic Incontinence Score (CCIS)], quality of life [Fecal-Incon

221 The Wexner incontinence score dropped from 16.5 +/- 2.5 for pre-SNS

222 The median Wexner fecal incontinence score was 9 (possible range: 0-20), and the

223 95% CI: 1.72-132; P = 0.036), improvement of incontinence scores at 6 months from baseline (OR: 6.29;

224 Comparison of composite evacuation and incontinence scores at 6, 18 and 24 months after surgery

225 Similarly, composite incontinence scores for PP and ITT populations showed no

226 4.3; P = 0.025), particularly improvement of incontinence scores from 3 to 6 months (OR: 41.5; 95% CI

227 Wexner incontinence scores improved significantly from a baseli

228 Incontinence scores were measured using a validated ques

229 ostate Cancer Index Composite (EPIC) urinary incontinence scores were similar at baseline as and 12 m

230 Fecal incontinence seems to be a problem.

231 l incontinence was evaluated using the Fecal Incontinence Severity Index (FISI).

232 ; or overall UI score of 3 or greater on the Incontinence Severity Index.

233 oint was change in St Mark's (Vaizey) faecal incontinence severity score between baseline and 24 week

234 n-group differences in secondary measures of incontinence severity, quality of life, patient satisfac

235 h as overactive bladder syndrome and urinary incontinence significantly increase with age.

236 (0.19) in the RN ratio, the odds of urinary incontinence status improvement or maintenance of contin

237 uality defined as the improvement of urinary incontinence status or maintenance of continent status p

238 There are an increasing number of urinary incontinence studies outside Europe and North America.

239 a preclinical canine model of stress urinary incontinence (SUI) and no measurable functional agonism

240 shes used in the treatment of stress urinary incontinence (SUI) and pelvic organ prolapse (POP) have

241 ntify risk factors related to stress urinary incontinence (SUI) and postnatal depression (PD) after b

242 ngs for the treatment of male stress urinary incontinence (SUI) has increased over the last decade.

243 Stress urinary incontinence (SUI) is a common and bothersome condition.

244 gan prolapse (POP) repair and stress urinary incontinence (SUI) to augment and strengthen weakened ti

245 Stress urinary incontinence (SUI) with more than 1 symptom or interval

246 surgical treatment for female stress urinary incontinence (SUI).

247 [0.24-0.39]), and a similar risk of further incontinence surgery (0.90 [0.73-1.11]) and later compli

248 Anti-incontinence surgery has high cure rates, but concerns a

249 r later postoperative complications, further incontinence surgery, or further prolapse surgery.

250 Stress incontinence surgery, the midurethral sling, is associat

251 ess after implantation was no previous fecal incontinence surgical treatment.

252 tistically significant difference in urinary incontinence symptoms at 12 months that did not meet the

253 oderate or severe stress and urgency urinary incontinence symptoms for at least 3 months, and at leas

254 ange between baseline and 12 months in mixed incontinence symptoms measured by the Urogenital Distres

255 lower urinary tract symptom, nearly 50% had incontinence symptoms, 40% had filling symptoms, and 18%

256 statectomy was associated with worse urinary incontinence than EBRT (-18.0 points; 95% CI, -20.5 to -

257 ater decrease in sexual function and urinary incontinence than either EBRT or active surveillance aft

258 ostatectomy were more likely to have urinary incontinence than were those undergoing radiotherapy at

259 nificant portion of whom report urge urinary incontinence that is inadequately treated with first-lin

260 neurologic disease) associated with urinary incontinence, the clinician should initiate unsupervised

261 Urinary incontinence, the involuntary loss of urine, is a common

262 High-quality, level 1 evidence for urinary incontinence therapy can guide clinicians in the treatme

263 e have not changed significantly for urinary incontinence, there have been recent advances with minim

264 tectomy reported clinically meaningful worse incontinence through 5 years compared with all other opt

265 The most common symptoms were incontinence to flatus (n = 86/132; 65.2%) and defaecato

266 d with hypervirulent ribotypes or with stool incontinence, to determine the rate of transmission.

267 ing regarding the treatment of mixed urinary incontinence, treatment generally begins with conservati

268 Among women with refractory urgency urinary incontinence, treatment with onabotulinumtoxinA compared

269 Urinary incontinence (UI) affects between 40 and 60% of people i

270 or over with a diagnosis of stroke; urinary incontinence (UI) as defined by the International Contin

271 ons on the nonsurgical management of urinary incontinence (UI) in women.

272 Urinary incontinence (UI) is common among women and contributes

273 Urinary incontinence (UI), a common malady in women, most often

274 re dysfunctional urination including urinary incontinence (UI).

275 Women without stress urinary incontinence undergoing vaginal surgery for pelvic-organ

276 ir breakdown, urinary retention, or residual incontinence up to 3 months after surgery.

277 sures to assess functional outcomes (urinary incontinence, urinary irritation and obstruction, bowel,

278 ndomised controlled trial (CONtrol of Faecal Incontinence using Distal NeuromodulaTion [CONFIDeNT]) i

279 on issues for these patients include urinary incontinence, vaginal stenosis, clitoral pain, and cosme

280 tio for pharmacological treatment of urinary incontinence was 2.2 (1.4-3.7) for both genders, and for

281 ed rate ratio for first diagnosis of urinary incontinence was 3.2 (2.7-3.7) in men and 2.7 (2.3-3.2)

282 n and 2.7 (2.3-3.2) in women, and for faecal incontinence was 6.0 (5.1-7.0) in men and 4.5 (3.8-5.2)

283 e surveillance at 3 months, worsened urinary incontinence was associated with radical prostatectomy (

284 h apical vaginal prolapse and stress urinary incontinence was conducted between 2008 and 2013 at 9 US

285 Fecal incontinence was evaluated using the Fecal Incontinence

286 ween-group difference in the odds of urinary incontinence was noted at 15 years.

287 Complete resolution of urgency urinary incontinence was reported by 13% and 27% of the women, r

288 Self-reported urinary incontinence was worse at 1 year for those in the adjuva

289 All 38 men with no baseline urinary incontinence were leak-free and pad-free by 9 months.

290 sis, results, and treatment of mixed urinary incontinence were selected for review.

291 nent patients (16.6%) reported postoperative incontinence (Wexner Score < 3), and 6 patients (8.5%) h

292 the pathophysiology of urinary retention and incontinence where sensory feedback may engage these ref

293 e, pain (spinal and peripheral), and urinary incontinence, whereas NOP antagonists have been investig

294 urethropexies, and for managing urge urinary incontinence with anticholinergic medications.

295 developed orthostatic hypotension or urinary incontinence with the requirement for urinary catheters

296 lity (level 1) evidence for treating urinary incontinence with weight loss, for treating stress urina

297 A review of the diagnosis of male urinary incontinence, with particular reference to studies publi

298 surgical options for the treatment of fecal incontinence within the context of established therapies

299 299 scenarios, including urinary retention, incontinence, wounds, urine volume measurement, urine sa

300 women residing in nursing homes have urinary incontinence, yet only 25% seek or receive treatment.